2006
DOI: 10.1016/j.jpeds.2006.03.014
|View full text |Cite
|
Sign up to set email alerts
|

Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: Summary statement of a First National Institutes of Health/Office of Rare Diseases conference

Abstract: Researchers and clinicians with expertise in autosomal recessive polycystic kidney disease and congenital hepatic fibrosis (ARPKD/CHF) and related fields met on May 5-6, 2005, on the National Institutes of Health (NIH) campus for a 1.5-day symposium sponsored by the NIH

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
53
0
5

Year Published

2008
2008
2017
2017

Publication Types

Select...
4
4

Relationship

1
7

Authors

Journals

citations
Cited by 81 publications
(58 citation statements)
references
References 34 publications
(39 reference statements)
0
53
0
5
Order By: Relevance
“…The PKHd1 gene is a very large gene with a complicated splicing pattern and makes genetic testing time consuming, expensive, and labor intensive. There is marked allelic heterogeneity and most patients are compound heterozygotes [25]. …”
Section: Clinical Presentationmentioning
confidence: 99%
“…The PKHd1 gene is a very large gene with a complicated splicing pattern and makes genetic testing time consuming, expensive, and labor intensive. There is marked allelic heterogeneity and most patients are compound heterozygotes [25]. …”
Section: Clinical Presentationmentioning
confidence: 99%
“…Las tasas de supervivencia son aproximadamente de 86% a los cinco años, 67 a 71% a los 10 años. [7][8][9][10][11][12] La hipertensión arterial es diagnosticada al nacimiento en 80% de los pacientes. 8 Sin embargo, en nuestro paciente, ni al nacimiento ni a la entrada del hospital, se documentó hipertensión arterial; ésta fue detectada de manera súbita y sin presencia de manifestaciones clínicas.…”
Section: Discussionunclassified
“…Se cree que en la fisiopatología de la hipertensión arterial hay activación local del sistema renina-angiotensina-aldosterona y retención de sodio en los conductos colectores ectásicos y quísticos. 9 Es importante mencionar que las complicaciones cardiovasculares secundarias a hipertensión arterial, como la hipertrofia cardiaca o la insuficiencia cardiaca, son causas de morbilidad y mortalidad elevadas, por lo que el tratamiento antihipertensivo debe ser iniciado oportunamente en estadios iniciales.…”
Section: Discussionunclassified
“…Portal hypertension with variceal bleeding, cholangitis and hepatic insufficiency are the most common problems associated with the hepatic component of the disease. 2 The plain radiographic findings of ARPKD-CHF include large flank masses displacing the bowel loops centrally, producing an appearance similar to ascites, and therefore referred to as the pseudoascites sign. 3 Sonographically the disease is characterized by nephromegaly, which in 60% of patients is massive, being more than 4 s.d.…”
Section: Denouement and Discussionmentioning
confidence: 99%
“…Discrete hyperechoic foci may occur, which are believed to be calcifications. 2,5 These echogenic foci are believed to correlate with renal failure. 5 Renal size stabilizes and may decrease over time if the patient survives.…”
Section: Denouement and Discussionmentioning
confidence: 99%